Omicia, Inc. Provides Early Access to Powerful Solution for Individual Genome Interpretation
Published: May 10, 2012
EMERYVILLE, Calif. & COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--Omicia, a privately held company offering integrated solutions for interpreting human genome sequences, announced today that it has initiated an early access program for its individual genome interpretation product. Through this product, Omicia will enable users to prioritize and identify disease genes and their variants using an intuitive and interactive web-based application environment. The solution was designed for clinical researchers in genomic and translational medicine. Omicia is providing a preview to attendees of The Biology of Genomes annual meeting taking place this week at the Cold Spring Harbor Laboratory on Long Island, NY.